Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shin, H.-J. Articles by Njenga, M. K. Search for Related Content PubMed PubMed Citation Articles by Shin, H.-J. Articles by Njenga, M. K.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2002, p. 1687-1693, Vol. 40, No. 5
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.5.1687-1693.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Molecular Epidemiology of Subgroup C Avian Pneumoviruses Isolated in the United States and Comparison with Subgroup A and B Viruses

Hyun-Jin Shin,¹ Kjerstin T. Cameron,¹ Janet A. Jacobs,² Elizabeth A. Turpin,² David A. Halvorson,¹ Sagar M. Goyal,¹ Kakambi V. Nagaraja,¹ Mahesh C. Kumar,³ Dale C. Lauer,⁴ Bruce S. Seal,² and M. Kariuki Njenga^1*

Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota 55108,¹ Southeast Poultry Research Laboratory, Agricultural Research Service, U.S. Department of Agriculture, Athens, Georgia 30605,² EBO Farms Atwater Laboratory, Atwater, Minnesota 56209,³ Minnesota Poultry Testing Laboratory, Minnesota Board of Animal Health, Willmar, Minnesota 56201⁴

Received 11 October 2001/ Returned for modification 29 December 2001/ Accepted 27 January 2002

Top Abstract Introduction Materials and Methods Results and Discussion References

 
The avian pneumovirus (APV) outbreak in the United States is concentrated in the north-central region, particularly in Minnesota, where more outbreaks in commercial turkeys occur in the spring (April to May) and autumn (October to December). Comparison of the nucleotide and amino acid sequences of nucleoprotein (N), phosphoprotein (P), matrix (M), fusion (F), and second matrix (M2) genes of 15 U.S. APV strains isolated between 1996 and 1999 revealed between 89 and 94% nucleotide sequence identity and 81 to 95% amino acid sequence identity. In contrast, genes from U.S. viruses had 41 to 77% nucleotide sequence identity and 52 to 78% predicted amino acid sequence identity with European subgroup A or B viruses, confirming that U.S. viruses belonged to a separate subgroup. Of the five proteins analyzed in U.S. viruses, P was the most variable (81% amino acid sequence identity) and N was the most conserved (95% amino acid sequence identity). Phylogenetic comparison of subgroups A, B, and C viruses indicated that A and B viruses were more closely related to each other than either A or B viruses were to C viruses.

Top Abstract Introduction Materials and Methods Results and Discussion References

 
The Turkey rhinotracheitis virus, commonly referred to as avian pneumovirus (APV), is a member of the Paramyxoviridae family that causes acute rhinotracheitis in turkeys that is characterized by coughing, nasal discharge, tracheal rales, foamy conjunctivitis, and sinusitis in turkeys of all ages. In laying birds, there is a transient drop in egg production, along with mild respiratory tract illness (11). Uncomplicated cases have low mortality (2 to 5%), but APV infections accompanied by secondary infections (bacterial and/or viral) can result in up to 25% mortality (11). APV was first detected in South Africa in 1978 but was isolated soon thereafter in the United Kingdom, France, Spain, Germany, Italy, The Netherlands, Israel, and Asia (1, 11). The United States was free of APV infection until 1996, when APV was isolated from turkeys in Colorado during a 10-month outbreak of upper respiratory disease (14, 35). The APV outbreak in Colorado was controlled by intense biosecurity measures, and the disease has not been reported there since early 1997 (14). However, APV was detected in 1997 in Minnesota, where the incidence of disease has increased over the past 4 years despite the establishment of biosecurity measures similar to those used in Colorado (3, 6, 10).

Mammalian pneumoviruses encode 10 proteins that include nonstructural (NS1 and NS2), nucleocapsid (N), phosphoprotein (P), matrix (M), small hydrophobic (SH), surface glycoprotein (G), fusion (F), second matrix (M2) and RNA-dependent RNA polymerase (L) genes. In contrast, APV lacks the NS1 and NS2 genes (29, 31) and has a smaller L gene than mammalian pneumoviruses (33). The gene order of APV is 3'-N-P-M-F-M2-SH-G-L-5' (20, 46). Based on these differences, the APVs were classified in the genus Metapneumovirus, whereas their mammalian counterparts belong to the genus Pneumovirus (29). Two subgroups (A and B) of APV were defined in Europe; these subgroups were initially based on the level of genetic variations in the attachment (G) glycoproteins of APV strains (12). Subsequent studies showed significant heterogeneity in M and F gene nucleotide sequences between the two subgroups so that the genetic composition of these genes could also be used to distinguish between the subgroups (32, 44, 45). However, there has been no comparative genetic analysis based on P and M2 genes across the subgroups because these genes have never been sequenced from subgroup B viruses.

Initial studies suggested that APV isolates from the United States were different antigenically and genetically from the European A and B subtypes (14, 35, 36). For example, an enzyme-linked immunosorbent assay (ELISA) developed with European APV isolates as antigen failed in detecting antibodies against the U.S. strain (14). In addition, sequence comparison of M and F genes from three 1997 APV isolates from the United States revealed that these genes shared 98% nucleotide sequence identity among one another, but only 60 to 70% nucleotide sequence identity with APV subgroup A and B viruses (35, 36). As a result of these differences, it was suggested that the U.S. isolates should be classified as subgroup C (35, 36). Anecdotal evidence from APV outbreaks in Minnesota suggested that turkeys infected early (i.e., at 1 to 3 weeks of age) could develop a second APV infection later, raising the possibility that multiple strains of virus may be responsible for the disease (16). To better understand the epidemiology of APV in the United States, the annual incidence of the disease and the genetic composition of 15 viruses isolated from naturally infected commercial turkeys over 4 years were investigated. In order to perform genetic comparison between the three subgroups of APV, several APV subgroup B (Hungary/657/4) genes were isolated and sequenced for the first time.

Top Abstract Introduction Materials and Methods Results and Discussion References

 
Viruses. Fourteen APV strains were isolated from naturally infected turkeys in the state of Minnesota between 1997 and 1999 (Table 1). Virus isolation was attempted from 110 samples collected from commercial turkeys showing clinical signs of APV infection. Nasal turbinate tissues or swabs from the choanal cleft and trachea were collected from exposed asymptomatic birds (in barns where other birds were showing overt clinical signs of APV) or from birds with early clinical signs (rales, mild infraorbital sinus swellings, etc.) and processed for APV isolation as described previously (7). Briefly, samples were homogenized and cultured in chicken embryo fibroblasts for five blind passages and then cultured in Vero cells. In Vero cells, cytopathic changes could be observed as early as in the second passage. Isolates were confirmed by immunofluorescence with APV-specific polyclonal antibody. The APV/Colorado isolate (APV/CO) and Hungary/657/4 (subgroup B APV) were obtained from National Veterinary Services Laboratory, Animal Plant Health Inspection Service, U.S. Department of Agriculture in Ames, Iowa. The subgroup B virus was propagated in Vero cells under biosafety level 3 conditions at the Southeast Poultry Research Laboratory, U.S. Department of Agriculture, Athens, Ga. After isolation, the Minnesota viruses were passaged for between 5 and 10 times before being sequenced, whereas the passage history of the European A and B viruses used in sequence comparisons was not known.

View this table: [in this window] [in a new window]

TABLE 1.  History of the AVPs isolated in the United Statesa

Monitoring the APV outbreak. To determine the annual incidence of APV outbreaks in United States, 72 privately owned turkey farms located in central and southern regions of Minnesota were monitored for APV outbreaks. Each farm had between 30,000 and 280,000 commercial turkeys housed in one to several barns. Turkey flocks were inspected daily for signs of respiratory disease. Upon development of clinical signs, turbinate tissues were collected from 10 birds for reverse transcription-PCR (RT-PCR) and serum samples were collected for ELISA (3, 37). The ELISA was performed routinely by using whole APV/CO lysate and turkey sera at a 1:40 dilution as described previously (7). An absorbance reading of at least 0.2 at a 490-nm wavelength in at least 5 of the 10 samples constituted a positive flock, whereas two to four positive samples constituted a suspect flock that was reanalyzed a week later for confirmation. The RT-PCR detection was performed as described previously (37). In addition, turkey sera from six counties with the highest incidence of APV (Kandiyohi, Meeker, Morrison, Stearn, Swift, and Todd) were collected from the rendering plant (10 samples per flock) and tested for APV antibodies. For the rendering-plant flocks, an absorbance reading of at least 0.2 at a 490-nm wavelength in at least 5 of the 10 samples constituted a positive flock, whereas fewer than 5 positive samples was considered negative for the purpose of statistical analysis. Typically, APV-positive flocks were taken for slaughter 4 to 6 weeks after the outbreaks. The monthly incidence of APV outbreaks (number of farms) was compared by using Student's t test.

RNA extraction, RT-PCR, cloning, and sequencing. The N, P, M, F, and M2 genes of each of the 15 viruses were amplified and sequenced for nucleotide and predicted amino acid comparison. RNA from the virus-infected Vero cells was extracted by using guanidinium thiocyanate-phenol-chloroform reagent (Gibco-BRL, Rockville, Md.) and reverse transcribed with random hexamer oligonucleotides (Gibco-BRL) with Moloney murine leukemia virus reverse transcriptase at 42°C for 1 h (4, 15). Primers for amplification of N, P, M, F, and M2 genes of APV were designed from consensus sequences of APV (36) (GenBank accession numbers AF187152, AF187153, AF176590, AF176591, and AF176592) as presented in Table 2. After RT, 5 to 10 µl of the reaction mixture was used for PCR. The cDNA was denatured at 95°C for 5 min, followed by 35 cycles of denaturation (95°C for 1 min), annealing (55°C for 1 min), and elongation (72°C for 1 min). The PCR products were gel purified (Qiagen, Valencia, Calif.) and cloned into PCR2.1 plasmid vector (Invitrogen, San Diego, Calif.) (22). The subcloned APV genes were sequenced with T7 forward and M13 reverse primers. Two independent clones of each gene plus the PCR products were sequenced for each of the 15 viruses with automated DNA sequencers (40).

View this table: [in this window] [in a new window]

TABLE 2.  Primers used for isolation of APV genes

Nucleic acid sequence analysis. Nucleotide sequence editing, prediction of amino acid sequences, and protein computer structure predictions were performed using Intelligenetics GeneWorks 2.5.1TM (Mountain View, Calif.) and DNAStar (Madison, Wis.) software. Alignments were performed by using the CLUSTALW method (42). The nonsynonymous and synonymous substitutions were determined by the method of Nei and Gojobori (24) in a molecular evolutionary genetics analysis program (17). To determine relationships among APV isolates, phylogenetic analysis of the aligned sequences was performed by using PAUP* software (41) by both parsimony and neighbor-joining analyses. Both analyses resulted in duplicate phylogenetic relationships and were evaluated by testing 2,000 bootstrap replicates. The nucleotide sequences of the five genes of APV subgroup A (N, P, F, M, and M2) and two genes of subgroup B (M and F) were as published (GenBank accession numbers Y14291 to Y14294, U37586, U22110, and U39295 to U39296). The bovine respiratory syncytial virus sequences were used as outgroups for comparative analysis across subgroups (21, 26, 34) (GenBank accession numbers M35076 and M82816). The nucleotide sequences for the 15 U.S. viruses have been submitted to GenBank with the following accession numbers: F genes, AAF01768 to AAF01772; M genes, AAG30828 to AAG30846; P genes, AY028569 to AY028582; N genes, AY028556 to AY028568; and M2 genes, AY028542 to AY028555. The accession numbers for APV/B virus (Hungary/647/4) N, P, and M2 gene nucleotide sequences are AF325442, AF325443, and AF356650, respectively.

Top Abstract Introduction Materials and Methods Results and Discussion References

 
Seasonal occurrence of APV outbreaks. To determine the seasonal pattern of APV outbreaks in United States, 72 turkey farms were monitored daily for clinical signs of APV over a 2-year period (January 1998 to December 1999), and outbreaks were confirmed by ELISA for APV antibodies (detected 2 weeks after the onset of clinical signs) or by RT-PCR for viral RNA (detected 3 to 10 days after onset of clinical signs). Approximately the same numbers of birds were maintained in the farms throughout the year. There were outbreaks on 55 farms during 1998 and on 109 farms during 1999, with some farms reporting more than one outbreak in a year. Over the 2-year period, 39% of the outbreaks occurred between April and May, whereas 40.8% occurred between October and December (Fig. 1), which was significantly higher than in the other 7 months (P < 0.001). The mean (± the standard deviation) number of farms that were positive for APV outbreaks in these high-incidence months (April to May and October to December) was 13.2 ± 7.5 farms per month, whereas the mean in the low-incidence months was 2.4 ± 1.3 farms per month. To further monitor the seasonal trend of APV outbreaks, APV tests (ELISA) were performed in all turkey flocks received for slaughter from six Minnesota counties previously shown to have the highest incidence of APV outbreaks (Kandiyohi, Meeker, Morrison, Stearns, Swift, and Todd counties). Turkey sera were collected at the rendering plant (10 samples per flock), which was typically 4 to 6 weeks after clinical APV disease because farmers waited this long in an effort to minimize the incidence of APV-induced air sacculitis detectable at slaughter, which resulted in bird condemnation. On average, 93 and 76 flocks per month were tested from the six counties in 1999 and 2000, respectively. The mean (± the standard error) percent APV-positive flocks from May to June and from November to January (a total of 5 months) was 83% ± 2.3% flocks per month, which was significantly higher than the 60% ± 3.6% APV-positive flocks per month in the other 7 months (February to April and July to October) of the year (P < 0.005, Fig. 1).

View larger version (38K): [in this window] [in a new window]

FIG. 1. High incidence of APV in spring and autumn. The monthly incidence of APV was analyzed in 72 turkey farms (black bars) by daily clinical evaluation over 2 years, and disease outbreak was confirmed by ELISA. The number of birds at each farm ranged from 30,000 to 280,000 turkeys. Data were based on ELISA tests of 10 samples from each flock showing clinical signs of APV. A flock was declared positive when at least 5 of the 10 samples gave a positive ELISA reading (optical density of 0.2). Flocks with two to five positive samples were retested a week later to confirm the result. In addition, turkey sera from flocks taken for slaughter from six Minnesota counties that had the highest incidence of APV (10 samples per flock) were tested for APV antibodies (shaded bars). Data are shown as the percent APV-positive flocks.

The high incidence of APV in spring (April to May) and autumn (October to December) may have been due to the migratory patterns of wild birds, which according to recent studies may be involved in spreading the virus (38, 39). RNA was isolated from nasal turbinate samples of wild sparrows, geese, swallows, and starlings (39). More recently, infectious APV (APV/MN12) was isolated from sentinel ducks placed in a pond neighboring a turkey farm (200 m away) and shown to have high nucleotide sequence identity with four APV strains (APV/MN4A, APV/MN4B, APV/MN4C, and APV/MN5) isolated from the neighboring turkey farm (38) (GenBank accession numbers AF368170 to AF368174). There are no studies documenting the seasonal trends of APV outbreaks in Europe. However, in both human and bovine respiratory syncytial viruses, seasonal activities have been observed, with most outbreaks being recorded during the rainy or colder months (5, 8, 25, 43).

Homogeneity of U.S. viruses. To determine whether the outbreaks in the United States were due to the emergence of genetically different APV strains, 14 viruses were isolated from the outbreaks in Minnesota over 3 years (1997 to 1999; Table 1) and the sequences of N, P, M, F, and M2 genes compared with the Colorado isolate (APV/CO). A total of 110 (59 turbinate pools and 51 swab pools) turkey samples were processed over the 3 years, resulting in 14 isolates.

The protein sizes and amino acid sequence comparison among the U.S. viruses and between U.S. viruses and European viruses are summarized in Table 3. Each gene contained one to two open reading frames, as well as noncoding sequences. The N gene consisted of 1,207 nucleotides in a single open reading frame encoding a protein of 394 amino acids. Both the nucleotide and the predicted amino acid sequence identity among the 15 U.S. isolates was 95%. The P gene contained 910 nucleotides encoding a single protein of 294 amino acids. The P gene was the most variable of those analyzed among the U.S. APV isolates, consisting of 89% nucleotide sequence identity and 81% predicted amino acid sequence identity (Table 3). The M genes from U.S. viruses had 871 nucleotides and encoded a single protein of 254 amino acids. The gene had a nucleotide sequence identity of 92% and a predicted amino acid sequence identity of 88% among the U.S. isolates. The M2 gene was 750 nucleotides in size with two open reading frames. The major open reading frame (positions 14 to 569) encoded a 184-amino-acid protein, whereas the second minor open reading frame (positions 525 to 740) encoded a small protein of 71 amino acids. The M2 nucleotide sequence identity was 91% and predicted amino acid sequence identity 86% among the U.S. isolates.

View this table: [in this window] [in a new window]

TABLE 3.  Comparison of N, P, M, F, and M2 proteins of subgroup A, B, and C APVs

The F gene sequences of U.S. viruses had 1,666 nucleotides, with a single open reading frame encoding a protein of 537 amino acids. The F gene protein had a cleavage site located between amino acids 103 and 104, whose connecting peptide (7 amino acids) was conserved among all U.S. isolates consisting of Arg-Lys-Ala-Arg/Phe-Val-Leu amino acids. In comparison, the connecting peptide for subgroup A viruses consists of Arg-Arg-Arg-Arg/Phe-Val-Leu, whereas that for subgroup B viruses consists of Arg-Lys-Lys-Arg/Phe-Val-Leu amino acids. The resultant F1 and F2 subunits were 103 and 431 amino acids long, respectively, for the U.S. isolates, a finding which is comparable to the corresponding F protein subunits of subgroup A and B viruses. The overall F protein amino acid sequence identity among the U.S. isolates was 91%, with the F1 subunit being more conserved than the F2 subunit, as observed in subgroup A and B viruses (23). Utilizing recently published partial F gene amino acid sequences (amino acids 315 to 421) from a potential subgroup D APV in France (GenBank accession numbers AF368170 to AJ400730), we compared these F protein amino acid sequences with the 15 U.S. isolates (subgroup C) and the viruses from subgroups A and B (2). As shown in Fig. 2, sequence alignment and phylogenetic analysis indicated that subgroups A, B, and D viruses were more closely related to each other than any of them was to the subgroup C viruses, reaffirming that the U.S. viruses are different from European viruses.

View larger version (32K): [in this window] [in a new window]

FIG. 2. Comparative amino acid sequence alignment and phylogenetic relationships among APVs based on fusion (F) protein. Sequences aligned and amino acid differences denoted by the single-letter code with consensus below are shown for amino acids 315 to 421 in order to compare viruses in subgroup A, B, C, and D viruses. After alignment, a rooted phylogram was generated by maximum-parsimony analysis by using bovine respiratory syncytial virus (BRSV) as an outgroup. Absolute distances are listed above each branch, with bootstrap confidence levels given in parentheses below. APV/MN1 to -11 and APV/CO represent viruses isolated from Minnesota (14 viruses) and Colorado (1 virus), respectively. The European subgroup A, B, and D viruses are also indicated, along with the country where they were isolated.

Analysis of nucleotide and amino acid sequence relatedness of various strains within a subgroup for bovine respiratory syncytial virus and human respiratory syncytial virus indicate that the percent identities ranged from 83.7 to 100% within a subgroup, whereas the nucleotide sequence identities between the two different subgroups ranged from 41 to 70% (27, 30). Our data indicate that there is high homogeneity among U.S. isolates (89 to 94% nucleotide sequence identity). On the other hand, U.S. isolates had 41 to 77% nucleotide identities compared to European (subgroup A and B) viruses, thus supporting their classification into a single new subgroup (35). Interestingly, the ratio of nonsynonymous nucleotide changes in the surface F gene between the APV/CO and 1997 isolates from Minnesota (APV/MN2A and APV/MN1B) was between 1.8 and 2.00 (9), suggesting that there was positive selection early as the virus spread within the United States (Fig. 3). In contrast, the ratio of nonsynonymous to synonymous changes in recent (i.e., 1999) Minnesota isolates (APV/MN9 to APV/MN11) compared to the 1997 isolates (APV/MN2A) was between 0.4 and 0.54, indicating minimal accumulation of nonsynonymous mutations after the establishment of APV in Minnesota (13).

View larger version (26K): [in this window] [in a new window]

FIG. 3. Phylogenetic relationships among APVs isolated in the United States. After alignment of contiguous nucleotide coding sequences for the nucleocapsid (N), phosphoprotein (P), matrix (M), and second matrix (M2) protein genes for 15 APVs isolated from United States, a cladogram was generated by maximum parsimony. Absolute distances are presented above each branch with bootstrap confidence levels in parentheses. The U.S. viruses were compared with subgroup A (APV/A) and B (APV/B) viruses from Europe.

Comparison of U.S. and European viruses. The U.S. isolates had between 62 and 65% nucleotide sequence identity with subgroup A viruses and 60 to 63% nucleotide sequence identity with subgroup B viruses (18, 19, 20, 32, 44, 45, 46). The predicted amino acid sequence identity among U.S. viruses was between 81 and 95%, whereas the identity between subgroups A, B, and C was between 46 and 77%, indicating that all of the U.S. viruses are relatively homogeneous but distinctly different from their European counterparts and supporting their classification into subgroup C (35, 36). The predicted N, P, M, and F proteins had between 84 and 91% identity between subgroup A and B viruses but 53 to 78% identity between subgroup A and C viruses and 52 to 77% identity between subgroup B and C viruses.

In conclusion, the data demonstrate a seasonal occurrence of APV outbreaks in the United States, with most outbreaks being reported in the spring and autumn. Analysis of genetic sequences of 15 APV isolates from the United States revealed a homogeneous subgroup of viruses different from the European viruses but with relatively few mutations over 4 years. An intriguing question is determining the level of homogeneity in the highly variable and immunogenic attachment G genes among U.S. viruses, which is the immediate focus of our research efforts. The mammalian pneumoviruses, including human respiratory syncytial virus and bovine respiratory syncytial virus have two subgroups of viruses: A and B (27, 28, 30). Therefore, the description of a third subgroup of APVs in our study and a recent report suggesting the emergence of a fourth subgroup may suggest that the avian paramyxoviruses are more heterogeneous than their mammalian counterparts (2).

 
We thank Allison Heath, Baldev Gulati, Evelyn Townsend, Alberto Back, Daniel Shaw, and Farris Jirjis for their assistance.

This work for funded by grants from the Minnesota Turkey Growers Association, the Minnesota Agriculture Experiment Station, the ARS, USDA CRIS project 6612-32000-015-085, and by U.S. Poultry and Egg Association grant number 404.

 
* Corresponding author. Mailing address: Department of Veterinary Pathobiology, University of Minnesota, 1971 Commonwealth Ave., St. Paul, MN 55108. Phone: (612) 625-2719. Fax: (612) 625-5203. E-mail: njeng001{at}tc.umn.edu.

Top Abstract Introduction Materials and Methods Results and Discussion References

 

1
1. Alexander, D. J. 1997. Newcastle disease and other Paramyxoviridae infections, p. 541-569. In B. W. Barnes, H. J. Beard, C. W. McDougald, and L. Saif, Jr. (ed.), Diseases of poultry, 10th ed. Iowa State University Press, Ames.
2
2. Bayon-Auboyer, M.-H., C. Arnauld, D. Toquin, and N. Eterradossi. 2000. Nucleotide sequences of the F, L, and G protein genes of two non-A/non-B avian pneumoviruses (APV) reveal a novel APV subgroup. J. Gen. Virol. 81:2723-2733.[Abstract/Free Full Text]
3
3. Chiang, S. J., A. M. Dar, S. M. Goyal, K. V. Nagaraja, D. A. Halvorson, and V. Kapur. 2000. A modified enzyme-liked immunosorbent assay for the detection of avian pneumovirus antibodies. J. Vet. Diagn. Investig. 12:381-384.[Abstract/Free Full Text]
4
4. Chomzcynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.[Medline]
5
5. Gendrel, D., N. Basse, P. Palmer, E. Marc, R. Taty-Taty, S. Ravilly, F. Moulin, J. Raymond, and P. Lebon. 1999. Coincidental outbreaks of rotavirus and respiratory syncytial virus in Paris: a survey from 1993 to 1998. Arch. Pediatr. 6:735-739.[CrossRef][Medline]
6
6. Goyal, S. M., S. Chiang, A. M. Dar, K. V. Nagaraja, D. P. Shaw, D. A. Halvorson, and V. Kapur. 2000. Isolation of avian pneumovirus from an outbreak of respiratory illness in Minnesota turkeys. J. Vet. Diagn. Investig. 12:166-168.[Abstract/Free Full Text]
7
7. Gulati, B. R., K. T. Cameron, B. S. Seal, S. M. Goyal, D. A. Halvorson, and M. K. Njenga. 2000. Development of a highly sensitive and specific enzyme-linked immunosorbent assay based on recombinant matrix protein for detection of avian pneumovirus antibodies. J. Clin. Microbiol. 38:4010-4014.[Abstract/Free Full Text]
8
8. Halstead, D. C., and S. G. Jenkins. 1998. Continuous non-seasonal epidemic of respiratory syncytial virus infection in the southeast United States. South. Med. J. 91:433-436.[Medline]
9
9. Ina, Y., and T. Gojobori. 1994. Statistical analysis of nucleotide sequences of the hemagglutinin gene of human influenza A viruses. Proc. Natl. Acad. Sci. USA 91:8388-8392.[Abstract/Free Full Text]
10
10. Jirjis, F. E., S. L. Noll, D. A. Halvorson, K. V. Nagaraja, E. L. Townsend, A. M. Sheikh, and D. P. Shaw. 2000. Avian pneumovirus infection in Minnesota turkeys: experimental reproduction of the disease. Avian Dis. 44:222-226.[CrossRef][Medline]
11
11. Jones, R. C. 1996. Avian pneumovirus infection: questions still unanswered. Avian Pathol. 25:639-648.[Medline]
12
12. Juhasz, K., and A. J. Easton. 1994. Extensive sequence variation in the attachment (G) protein gene of avian pneumovirus: evidence for two distinct subgroups. J. Gen. Virol. 75:2873-2880.[Abstract/Free Full Text]
13
13. Kimura, M. 1977. Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature 267:275-276.[CrossRef][Medline]
14
14. Kleven, S. H. 1997. Report of the Committee: transmissible diseases of poultry and other avian species, p. 486-491. In Proceedings of the U.S. Animal Health Association 101st Annual Meeting. U.S. Animal Health Association, Washington, D.C.
15
15. Kotewicz, M. L., C. M. Sampson, D. E. D'Alesio, and G. F. Gerard. 1988. Isolation of cloned Maloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity. Nucleic Acids Res. 16:265-277.[Abstract/Free Full Text]
16
16. Kumar, M. C. 1999. Epidemiology of avian pneumovirus infection. North Central Avian Disease Conference, St. Paul, Minn.
17
17. Kumar, S., K. Tamura, and M. Nei. 1993. MEGA: molecular evolutionary genetics analysis, version 1.01. Pennsylvania State University, University Park.
18
18. Li, J., R. Ling, J. S. Randhawa, K. Shaw, P. J. Davis, K. Juhasz, C. R. Pringle, A. J. Easton, and D. Cavanagh. 1996. Sequence of the nucleocapsid protein gene of subgroup A and B avian pneumoviruses. Virus Res. 41:185-191.[CrossRef][Medline]
19
19. Ling, R., P. J. Davis, Q. Yu, C. M. Wood, C. R. Pringle, D. Cavanagh, and A. J. Easton. 1995. Sequence and in vitro expression of the phosphoprotein gene of avian pneumovirus. Avian Res. 36:247-257.
20
20. Ling, R., A. J. Easton, and C. R. Pringle. 1992. Sequence analysis of the 22K, SH, and G genes of turkey rhinotracheitis virus and their intergenic regions reveals a gene order different from that of other pneumoviruses. J. Gen. Virol. 73:1709-1715.[Abstract/Free Full Text]
21
21. Mallipeddi, S. K., and S. K. Samal. 1992. Sequence comparison between the phosphoprotein mRNAs of human and bovine respiratory syncytial viruses identifies a divergent domain in the predicted protein. J. Gen. Virol. 72:2441-2444.
22
22. Mead, D. A., N. K. Pey, C. Herrnstadt, R. A. Marcil, and L. M. Smith. 1991. A universal method for the direct cloning of PCR amplified nucleic acid. Bio/Technology 9:657-662.[CrossRef][Medline]
23
23. Naylor, C. J., P. Britton, and D. Cavanagh. 1998. The ectodomains but not the transmembrane domains of the fusion proteins of subtypes A and B avian pneumovirus are conserved to a similar extent as those of human respiratory syncytial virus. J. Gen. Virol. 79:1393-1398.[Abstract]
24
24. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.[Abstract]
25
25. O'Kelly, E. A., and I. B. Hillary. 1991. Epidemiology of respiratory syncytial virus infection among infants over three winter seasons. Ireland J. Med. Sci. 160:12-16.
26
26. Pastey, M. K., and S. K. Samal. 1993. Structure and sequence comparison of bovine respiratory syncytial virus fusion protein. Virus Res. 29:195-202.[CrossRef][Medline]
27
27. Peret, T. C. T., C. B. Hall, K. C. Schnabel, J. A. Golub, and L. J. Anderson. 1998. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J. Gen. Virol. 79:2221-2229.[Abstract]
28
28. Peret, T. C. T., C. B. Hall, G. W. Hammond, P. A. Pedra, G. A. Storch, W. M. Sullender, C. Tsou, and L. J. Anderson. 2000. Circulation patterns of group A and B strains human respiratory syncytial virus genotypes in five communities in North America. J. Infect. Dis. 181:1891-1896.[CrossRef][Medline]
29
29. Pringle, C. R. 1996. Virus taxonomy 1996: a bulletin from the Xth International Congress of Virology in Jerusalem. Arch. Virol. 141:2251-2256.[CrossRef][Medline]
30
30. Prozzi, D., K. Walravens, J. P. M. Langedij, F. Daus, J. A. Kramps, and J.-J. Letesson. 1997. Antigenic and molecular analysis of the variability of bovine respiratory syncytial virus G protein. J. Gen. Virol. 78:359-366.[Abstract]
31
31. Randhawa, J. S., A. C. Marriott, C. R. Pringle, and A. J. Easton. 1997. Rescue of synthetic minireplicons establishes the absence of the NS1 and NS2 genes from avian pneumovirus. J. Virol. 71:9849-9854.[Abstract]
32
32. Randhawa, J. S., C. R. Pringle, and A. J. Easton. 1996. Nucleotide sequence of the matrix protein gene of a subgroup B avian pneumovirus. Virus Genes 12:179-183.[CrossRef][Medline]
33
33. Randhawa, J. S., S. D. Wilson, K. P. Tolley, D. Cavanagh, C. R. Pringle, and A. J. Easton. 1996. Nucleotide sequence of the gene encoding the viral polymerase of avian pneumovirus. J. Gen. Virol. 77:3047-3051.[Abstract/Free Full Text]
34
34. Samal, S. K., and M. Zamora. 1991. Nucleotide sequence analysis of a matrix and small hydrophobic protein dicistronic mRNA of bovine respiratory syncytial virus demonstrates extensive sequence divergence of a small hydrophobic protein from that of human respiratory syncytial virus. J. Gen. Virol. 72:1715-1720.[Abstract/Free Full Text]
35
35. Seal, B. S. 1998. Matrix protein gene nucleotide and predicted amino acid sequence demonstrate that the first U.S. avian pneumovirus isolate is distinct from European strains. Virus Res. 58:45-52.[CrossRef][Medline]
36
36. Seal, B. S., H. S. Sellers, and R. J. Meinersmann. 2000. Fusion protein predicted amino acid sequence of the first U.S. avian pneumovirus isolate and lack of heterogeneity among other U.S. isolates. Virus Res. 66:139-147.[CrossRef][Medline]
37
37. Shin, H. J., G. Rajashekara, F. F. Jirjis, D. P. Shaw, S. M. Goyal, D. A. Halvorson, and K. V. Nagaraja. 2000. Specific detection of avian pneumovirus U.S. isolates by RT-PCR. Arch. Virol. 145:1239-1246.[CrossRef][Medline]
38
38. Shin, H. J., K. V. Nagaraja, B. McComb, D. A. Halvorson, F. F. Jirjis, D. P. Shaw, B. S. Seal, and M. Kariuki Njenga. 2002. Isolation of avian pneumovirus from mallard ducks that is genetically similar to viruses isolated from neighboring commercial turkeys. Virus Res. 83:207-212.[CrossRef][Medline]
39
39. Shin, H. J., M. K. Njenga, B. McComb, D. A. Halvorson, and K. V. Nagaraja. 2000. Avian pneumovirus RNA from wild and sentinel birds in the United States has genetic homology with APV isolates from domestic turkeys. J. Clin. Microbiol. 38:4282-4284.[Abstract/Free Full Text]
40
40. Smith, L. M., J. Z. Sanders, R. J. Kaiser, P. Hughs, C. Dodd, C. R. Connell, C. Heines, S. B. H. Kent, and L. E. Hood. 1986. Fluorescence detection in automated DNA sequence analysis. Nature 321:673-681.
41
41. Swofford, D. 1998. PAUP*4.0: phylogenetic analysis using parsimony. Sinauer Associates/Smithsonian Institution, Sunderland, Mass.
42
42. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.[Abstract/Free Full Text]
43
43. Van der Poel, W. H., J. A. Kramps, W. G. Middel, J. T. Van Oirschot, and A. Brand. 1993. Dynamics of bovine respiratory syncytial virus infections: a longitudinal epidemiological study in diary herds. Arch. Virol. 133:319-321.
44
44. Yu, Q., P. J. Davis, T. Barret, M. M. Binns, M. E. G. Boursnell, and D. Cavanagh. 1991. Deduced amino acid sequence of the fusion glycoprotein of turkey rhinotracheitis virus has greater identity with that of human respiratory syncytial virus, a pneumovirus, that that of paramyxoviruses and morbilliviruses. J. Gen. Virol. 72:75-81.[Abstract/Free Full Text]
45
45. Yu, Q., P. J. Davis, J. Li, and D. Cavanagh. 1992. Cloning and sequencing of the matrix protein (M) gene of turkey rhinotracheitis virus reveal a gene order different from that of respiratory syncytial virus. Virology 186:426-434.[CrossRef][Medline]
46
46. Yu, Q., P. J. Davis, T. D. K. Brown, and D. Cavanagh. 1992. Sequence and in vitro expression of the M2 gene of turkey rhinotracheitis pneumovirus. J. Gen. Virol. 73:1355-1363.[Abstract/Free Full Text]

---

Journal of Clinical Microbiology, May 2002, p. 1687-1693, Vol. 40, No. 5
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.5.1687-1693.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Padhi, A., Poss, M. (2009). Population Dynamics and Rates of Molecular Evolution of a Recently Emerged Paramyxovirus, Avian Metapneumovirus Subtype C. J. Virol. 83: 2015-2019 [Abstract] [Full Text]  
• Bennett, R. S., LaRue, R., Shaw, D., Yu, Q., Nagaraja, K. V., Halvorson, D. A., Njenga, M. K. (2005). A Wild Goose Metapneumovirus Containing a Large Attachment Glycoprotein Is Avirulent but Immunoprotective in Domestic Turkeys. J. Virol. 79: 14834-14842 [Abstract] [Full Text]  
• Toquin, D., de Boisseson, C., Beven, V., Senne, D. A., Eterradossi, N. (2003). Subgroup C avian metapneumovirus (MPV) and the recently isolated human MPV exhibit a common organization but have extensive sequence divergence in their putative SH and G genes. J. Gen. Virol. 84: 2169-2178 [Abstract] [Full Text]  
• Venter, M., Rock, M., Puren, A. J., Tiemessen, C. T., Crowe, J. E. Jr. (2003). Respiratory Syncytial Virus Nucleoprotein-Specific Cytotoxic T-Cell Epitopes in a South African Population of Diverse HLA Types Are Conserved in Circulating Field Strains. J. Virol. 77: 7319-7329 [Abstract] [Full Text]  
• Alvarez, R., Lwamba, H. M., Kapczynski, D. R., Njenga, M. K., Seal, B. S. (2003). Nucleotide and Predicted Amino Acid Sequence-Based Analysis of the Avian Metapneumovirus Type C Cell Attachment Glycoprotein Gene: Phylogenetic Analysis and Molecular Epidemiology of U.S. Pneumoviruses. J. Clin. Microbiol. 41: 1730-1735 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shin, H.-J. Articles by Njenga, M. K. Search for Related Content PubMed PubMed Citation Articles by Shin, H.-J. Articles by Njenga, M. K.